Merck asks US FDA to authorize promising anti-COVID pill
Drugmaker Merck NSE 0.23 % asked U.S. regulators Monday to authorize its pill against...
Read MoreOct 21, 2021 | Regulatory Affairs
Drugmaker Merck NSE 0.23 % asked U.S. regulators Monday to authorize its pill against...
Read MoreOct 21, 2021 | Regulatory Affairs
India has delayed committing supplies of vaccine to the COVAX global sharing platform, two sources...
Read MoreOct 21, 2021 | Regulatory Affairs
After getting approval from Subject Expert Committee (SEC) for Covaxin to be used for children in...
Read MoreOct 21, 2021 | Medical Device
Medical device recalls require speed to ensure patient safety. But the system used to pull...
Read MoreSep 15, 2021 | Medical Device
As more connected medical devices are built on AI, cybersecurity risks will increase as well...
Read MoreM | T | W | T | F | S | S |
---|---|---|---|---|---|---|
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 | 31 |